Latest News & Features
Americas
AbbVie has used a “drip feed” of patents to secure more than nine years of extra exclusivity on blood cancer drug Imbruvica, a new report has revealed. 20 July 2020
Big Pharma
A US federal court has thrown out an appeal from Ono Pharmaceutical and a Nobel Prize-winning immunologist, in a dispute over who made groundbreaking discoveries in cancer therapy. 16 July 2020
Plant Varieties
Plant industry associations say “reason and fairness” will be needed from both growers and breeders as royalty payments mount. 16 July 2020
Biotechnology
As the UK Supreme Court reverses a Court of Appeal decision relating to sufficiency, the ruling leaves patent applicants in a potentially difficult position, argues David Fyfield of Charles Russell Speechlys. 16 July 2020
Biotechnology
The US International Trade Commission (USITC) will take another look at whether German orthopedics company Zimmer Biomet violated the IP rights of medical technology company Heraeus, it announced yesterday, Monday 13 July. 14 July 2020
Biotechnology
China’s Junshi Biosciences has licensed technology to produce an antibody against COVID-19 from Swiss biotechnology firm Lonza. 14 July 2020
article
UK Intellectual Property Office Perspective: Views on the Current Patenting Landscape - and COVID-19
Join the live broadcast to take part in the discussion with the UKIPO. Topics include: 14 July 2020
Generics
The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use. 10 July 2020
Big Pharma
An attempt to obtain a supplementary protection certificate ended up raising the bar to achieving this coveted IP, as Joel Beevers and Michael Pears of Potter Clarkson explain. 10 July 2020
Big Pharma
The rush to open access to IP-protected tech, medicines and devices in the fight against COVID-19 could cause problems later, argues MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch. 10 July 2020